CClinicalTrials.gg
CompletedNCT05777382QoLUpdated Mar 21, 2023

Quality of Life of Postnatal Mothers Attending Maternal and Child Health Clinic in Biratnagar

An observational study in Quality of Life, sponsored by Tribhuvan University, Nepal. Completed at 1 site in Nepal. Per ClinicalTrials.gov, last updated 2023-03-21.

Sponsored by Tribhuvan University, Nepal · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
129
Sex
All
01

Study summary

Objectives: Assessing health-related quality of life (HRQoL) and its predictors is essential for providing adequate healthcare and developing necessary interventions in women post-delivery. This study intended to determine the HRQoL score and predictors among women post-delivery in Nepal.

Methodology: This was a cross-sectional study using non-probability sampling conducted at the Maternal and Child Health (MCH) Clinic of Koshi Hospital, Province 1, Nepal. The study participants were 129 women post-delivery to 12 months who visited the MCH clinic from 2 September 2018 to 28 September 2018. Outcome measures were socio-demographic, clinical indicators, obstetric indicators, and their relation with overall health-related quality of life score of post-delivery mothers using Short Form Health Survey (SF-36) Version 1.

Read the detailed description

This cross-sectional study involved women post-delivery to 12 months who visited the Maternal and Child Health (MCH) Clinic of Koshi Hospital, Province 1, Nepal. The study population included the mothers who attended the MCH clinic from post-delivery to 12 months post-delivery. Mothers with psychiatric disorders were excluded from the study population. The investigators used a non-probability purposive sampling technique to select mothers meeting the inclusion criteria. The investigators used Short Form Health Survey (SF-36) Version 1.0 to assess study participants' HRQoL after obtaining permission for Research and Development (RAND). RAND SF-36 was already validated for use in Nepal by Bhandari et al. However, the investigators again pretested the translated Nepali SF-36 among 13 mothers in the MCH Clinic of Tribhuvan University Teaching Hospital. Cronbach's alpha was used to test the reliability, and the reported value was 0.752. Patient participants were involved in the study's pretesting. However, there was no public involvement in the research.

Independent variables: Age of mother, education status, ethnicity, religion, occupation, family income, type of family, family support, parity, number of living children, the desirability of pregnancy, mode of delivery, postpartum duration, place of delivery, and complications in recent delivery.

Dependent variable: Overall health-related quality of life score of post-delivery mothers were used.

Data was collected through face-to-face interviews using the RAND SF-36 Nepali version questionnaire from 2 September 2018 to 28 September 2018. The investigators collected a total of 129 responses. Descriptive statistics, i.e., number, percentage, mean, and standard deviation, were used to describe the demographic and obstetric variables. Mann-Whitney U test was applied to compare postnatal mothers' quality of life in different delivery modes. Similarly, Krushkal-Wallis H and Mann-Whitney U tests were used to examine the difference between the quality of life of postnatal mothers with selected socio-demographic and obstetric variables. Statistical significance was considered with a p-value ≤ 0.05.

02

Conditions studied

  • Quality of Life
03

In context

Lead sponsor

Tribhuvan University, Nepal is the lead sponsor of 16 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population included the mothers who attended the MCH clinic from post-delivery to 12 months post-delivery

Inclusion criteria

  • The study population included the mothers who attended the MCH clinic from post-delivery to 12 months post-delivery

Exclusion criteria

Exclusion Criteria:

  • Mothers with psychiatric disorders were excluded from the study population.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
129 participants (actual)
Patient registry
No

Interventions

  • Otherinquiry to postnatal mothers

    structured questionnaires was asked to postnatal mothers

06

What researchers measure

Primary outcomes

  1. Quality of Life in Post delivery mothers using RAND 36-Item Short Form Health Survey (SF-36)

    Quality of life in Post delivery mothers using RAND 36-Item Short Form Health Survey ranging from 0 to 100, with higher score meaning better quality of life

    Time frame: 3 months

07

Study locations

1 site
  • Koshi Hospital
    Biratnagar, Province 1 56700, Nepal
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05777382
Lead sponsor
Tribhuvan University, Nepal
Responsible party
Pratiksha Chapagain (Principal Investigator, Tribhuvan University, Nepal) — Principal investigator
First posted
Mar 21, 2023
Start date
Aug 12, 2018
Primary completion
Oct 12, 2018
Completion
Apr 15, 2019
Last update
Mar 21, 2023

Study contacts

Pratiksha Chapagain, MSc Nursing
principal investigator · Maharajgunj Nursing Campus, Tribhuvan University, Institute of Medicine, Kathmandu, Nepal

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion